FXTM information and reviews
FXTM
93%
IronFX information and reviews
IronFX
92%
Libertex information and reviews
Libertex
91%
ETX Capital information and reviews
ETX Capital
90%
FxPro information and reviews
FxPro
89%
FIBO Group information and reviews
FIBO Group
88%
EUR/USD
1.1916
GBP/USD
1.394
USD/JPY
110.2129
USD/CHF
0.9175
USD/CAD
1.2349
EUR/JPY
131.3321

Trade and invest in health and biotech stocks


10 April 2020

The world is on edge as it tries to find a solution to the coronavirus pandemic, with the markets having lost close to 30% in the last few weeks.

Health and biotech companies are at the forefront, with Johnson and Johnson and Sanofi both working on a COVID-19 vaccine; Pfizer offering talent, tools and manufacturing capabilities; and Novartis creating a $20m support fund, as well as donating its malaria drug to patients.

How can you join the battle?

We are delighted to announce a small, but important extension of our coverage of the health and biotechnology companies, now available as CFDs (Contracts for Difference) on our Trade.MT5 account:

Also, the following common stocks are now available to our clients with Invest.MT5 account:

These instruments join our existing line up of health and biotech stocks, including:

Additionally, you can access more than 100 companies in other segments of the healthcare industry plus 13 exchange-traded funds (ETFs) specialised in healthcare & biotech.

In order to group instruments by industries, open Contract Specifications and then click "Sort by industry group" or "Sort by category".

Keep reading to learn about how you can start trading and investing today.

#source

Related

HotForex rewards clients with Returns on Free Margin

Global multi-asset broker HotForex has announced that its exclusive reward program ROFM (Return on Free Margin) is available again offering new and existing...

18 Jun 2021

XpTrade multi-asset platform

Benefit from trading with the bespoke, world's most popular trading platform, XpTrade. Millions of traders and investors are using the XpTrade for trading...

18 Jun 2021

LegacyFX's Robust Tool Offering Setting it Apart from Competition

LegacyFX continues to maintain its commitment to transparency and trader education. Multi-asset trading specialist, LegacyFX continues to add to its comprehensive tool suite...

18 Jun 2021

Advantages of Trading Indices with OBRinvest

Indices are tools used to measure the performance of some group of similar assets in a measured and standard way. Most people recognize the indices that...

17 Jun 2021

Innovative fintech Exinity launches Exinity Trader PRO

Exinity aims to help ambitious individuals build and manage their own wealth through risk-driven trading and investing. Exinity Trader PRO is Exinity's first product

16 Jun 2021

New Stocks and Cryptocurrencies at FxPro

To satisfy our clients' demands, we are pleased to announce that we have just expanded our CFD product offering to include 38 of the hottest new stocks in the market and...

16 Jun 2021


Editors' Picks

© 2006-2021 Forex-Ratings.com

The usage of this website constitutes acceptance of the following legal information.
Any contracts of financial instruments offered to conclude bear high risks and may result in the full loss of the deposited funds. Prior to making transactions one should get acquainted with the risks to which they relate. All the information featured on the website (reviews, brokers' news, comments, analysis, quotes, forecasts or other information materials provided by Forex Ratings, as well as information provided by the partners), including graphical information about the forex companies, brokers and dealing desks, is intended solely for informational purposes, is not a means of advertising them, and doesn't imply direct instructions for investing. Forex Ratings shall not be liable for any loss, including unlimited loss of funds, which may arise directly or indirectly from the usage of this information. The editorial staff of the website does not bear any responsibility whatsoever for the content of the comments or reviews made by the site users about the forex companies. The entire responsibility for the contents rests with the commentators. Reprint of the materials is available only with the permission of the editorial staff.
We use cookies to improve your experience and to make your stay with us more comfortable. By using Forex-Ratings.com website you agree to the cookies policy.